Nav: Home

Analysis of HIV-1B in Indonesia illuminates transmission dynamics of the virus

October 03, 2019

Research into the molecular phylogeny (evolutionary history) of the HIV-1B virus in Indonesia has succeeded in illuminating the transmission period and routes for three clades (main branches of the virus). This includes a clade thought to be unique to Indonesia, as well as clades that spread from Thailand, Europe and America in the 1970s and 1980s.

The study was made possible through a research collaboration between Kobe University and Indonesia's Airlangga University, with funding from AMED's J-GRID program (see acknowledgments). The group consisted of Professor Masanori Kameoka and Assistant Professor Tomohiro Kotaki (both from the Department of Public Health at Kobe University's Graduate School of Health Sciences), Research Assistant Shuhei Ueda (Center for Infectious Diseases at Kobe University's Graduate School of Medicine), Professor Nasronudin (Airlangga University) and Doctor Kazushi Motomura of the Osaka Institute of Public Health.

These results were published in the international journal 'Scientific Reports' on September 27th, 2019.

Introduction

HIV (Human Immunodeficiency Virus) develops into AIDS (Acquired Immunodeficiency Syndrome), which continues to be a major health threat since the first case was discovered in 1981.

The genetic makeup of HIV adapts and changes easily. For example. HIV-1 M (Major) is the most widely spread type of HIV in the world, and for HIV-1 M alone, there are over one hundred strains within each of its nine subtypes.

HIV-1's subtype B (HIV-1B) is thought to have originated in the Democratic Republic of Congo in Central Africa, from where it spread to Haiti and America. It was subsequently transmitted to Europe and Asia, and is now found all over the globe.

Consisting of over 17,500 islands, Indonesia has the fourth largest population in the world. It also has the most instances of HIV transmission in South East Asia, with the CRF01_AE form as the predominant subtype. HIV-1 subtype B (HIV-1B) is also widely prevalent. Although rates of infection have been decreasing in Indonesia, it still remains a significant public health issue. However, many aspects regarding the origins, transmission and evolution of the virus in Indonesia are not well understood.

Methodology

For this research, peripheral blood samples were taken from HIV patients at medical institutions on Indonesia's main islands of Java, Sumatra, Papua, Sulawesi and various others. Thirty two sequences of HIV-1B genes were identified. The evolution of these genes was then analyzed using a database of closely related HIV-1B sequences. These phylogenetic analyses revealed that the main type of HIV-1B in Indonesia is the Indonesian clade, followed by Chinese and American clades.

Subsequent in-depth analysis of the molecular phylogeny of these three clades revealed how they may have travelled to Indonesia. The results suggest that the Indonesian clade originated in America. It is then thought to have developed into a unique strain in Indonesia after arriving in the country in the latter half of the 1980s. The Chinese clade spread from Thailand in the late 80s, with the American clade being transmitted via Europe in the mid-80s (Figure 1). Overall, the research found that HIV-1B was introduced to Indonesia multiple times via Thailand, Europe and America throughout the 1970s and 1980s (with the earliest estimated introduction of the virus being around 1961).
-end-
Further Research

Further analysis of other strains found in Indonesia will be carried out in order to understand more about virus origins and transmission. It is vital to accurately understand the molecular phylogeny of the virus as the number of HIV-1B strains continues to increase.

To elucidate the relationship between these strains in more detail, further genome information needs to be collected in South-East Asian countries. It is hoped that the data accumulated will be utilized for the worldwide prevention of widespread HIV transmission.

Acknowledgements

This research was made possible with support from the Japan Agency for Medical Research and Development (AMED)'s Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) Program.

Kobe University

Related Hiv Articles:

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).
Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.
Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.
The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.
The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.
Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.
NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
First ever living donor HIV-to-HIV kidney transplant
For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV.
The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.
Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.
More HIV News and HIV Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.